avrg: A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RELA
|
ENSG00000173039.14 | RELA |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RELA | hg19_v2_chr11_-_65429891_65429915 | 0.82 | 1.8e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_-_62203808 | 4.38 |
ENST00000467148.1 |
HELZ2 |
helicase with zinc finger 2, transcriptional coactivator |
chr6_+_138188351 | 4.37 |
ENST00000421450.1 |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
chr2_-_191885686 | 4.28 |
ENST00000432058.1 |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
chr9_-_21077939 | 3.78 |
ENST00000380232.2 |
IFNB1 |
interferon, beta 1, fibroblast |
chr14_-_35873856 | 3.56 |
ENST00000553342.1 ENST00000216797.5 ENST00000557140.1 |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
chr17_-_34207295 | 3.26 |
ENST00000463941.1 ENST00000293272.3 |
CCL5 |
chemokine (C-C motif) ligand 5 |
chr6_+_29691056 | 3.19 |
ENST00000414333.1 ENST00000334668.4 ENST00000259951.7 |
HLA-F |
major histocompatibility complex, class I, F |
chr19_+_39759154 | 3.18 |
ENST00000331982.5 |
IFNL2 |
interferon, lambda 2 |
chr6_+_138188551 | 3.10 |
ENST00000237289.4 ENST00000433680.1 |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
chr6_+_29691198 | 3.02 |
ENST00000440587.2 ENST00000434407.2 |
HLA-F |
major histocompatibility complex, class I, F |
chr6_+_138188378 | 2.94 |
ENST00000420009.1 |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
chr2_-_163175133 | 2.75 |
ENST00000421365.2 ENST00000263642.2 |
IFIH1 |
interferon induced with helicase C domain 1 |
chr10_+_104154229 | 2.64 |
ENST00000428099.1 ENST00000369966.3 |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr19_+_45504688 | 2.62 |
ENST00000221452.8 ENST00000540120.1 ENST00000505236.1 |
RELB |
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr11_+_102188272 | 2.59 |
ENST00000532808.1 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chr5_-_150460914 | 2.56 |
ENST00000389378.2 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr19_-_39735646 | 2.27 |
ENST00000413851.2 |
IFNL3 |
interferon, lambda 3 |
chr7_+_22766766 | 2.26 |
ENST00000426291.1 ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6 |
interleukin 6 (interferon, beta 2) |
chr4_-_74864386 | 2.15 |
ENST00000296027.4 |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
chr1_+_6845384 | 2.03 |
ENST00000303635.7 |
CAMTA1 |
calmodulin binding transcription activator 1 |
chr17_+_40440481 | 1.97 |
ENST00000590726.2 ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A |
signal transducer and activator of transcription 5A |
chr7_-_93520259 | 1.93 |
ENST00000222543.5 |
TFPI2 |
tissue factor pathway inhibitor 2 |
chr5_-_150460539 | 1.91 |
ENST00000520931.1 ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr7_-_93520191 | 1.87 |
ENST00000545378.1 |
TFPI2 |
tissue factor pathway inhibitor 2 |
chr5_-_150467221 | 1.85 |
ENST00000522226.1 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr19_+_4229495 | 1.83 |
ENST00000221847.5 |
EBI3 |
Epstein-Barr virus induced 3 |
chr4_-_76957214 | 1.75 |
ENST00000306621.3 |
CXCL11 |
chemokine (C-X-C motif) ligand 11 |
chr7_+_143078379 | 1.75 |
ENST00000449630.1 ENST00000457235.1 |
ZYX |
zyxin |
chr11_+_102188224 | 1.74 |
ENST00000263464.3 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chr14_+_103589789 | 1.67 |
ENST00000558056.1 ENST00000560869.1 |
TNFAIP2 |
tumor necrosis factor, alpha-induced protein 2 |
chr10_+_99609996 | 1.66 |
ENST00000370602.1 |
GOLGA7B |
golgin A7 family, member B |
chr4_-_185395191 | 1.54 |
ENST00000510814.1 ENST00000507523.1 ENST00000506230.1 |
IRF2 |
interferon regulatory factor 2 |
chr3_-_156878482 | 1.52 |
ENST00000295925.4 |
CCNL1 |
cyclin L1 |
chr3_+_101546827 | 1.45 |
ENST00000461724.1 ENST00000483180.1 ENST00000394054.2 |
NFKBIZ |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
chr14_-_24616426 | 1.44 |
ENST00000216802.5 |
PSME2 |
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr9_-_136344197 | 1.44 |
ENST00000414172.1 ENST00000371897.4 |
SLC2A6 |
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr4_+_74735102 | 1.44 |
ENST00000395761.3 |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr19_+_10381769 | 1.43 |
ENST00000423829.2 ENST00000588645.1 |
ICAM1 |
intercellular adhesion molecule 1 |
chr4_-_74964904 | 1.42 |
ENST00000508487.2 |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
chr9_-_32526299 | 1.42 |
ENST00000379882.1 ENST00000379883.2 |
DDX58 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr4_+_4861385 | 1.38 |
ENST00000382723.4 |
MSX1 |
msh homeobox 1 |
chr12_+_48499883 | 1.35 |
ENST00000546755.1 ENST00000549366.1 ENST00000552792.1 |
PFKM |
phosphofructokinase, muscle |
chr4_-_74904398 | 1.28 |
ENST00000296026.4 |
CXCL3 |
chemokine (C-X-C motif) ligand 3 |
chr9_-_32526184 | 1.28 |
ENST00000545044.1 ENST00000379868.1 |
DDX58 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr20_+_1115821 | 1.26 |
ENST00000435720.1 |
PSMF1 |
proteasome (prosome, macropain) inhibitor subunit 1 (PI31) |
chr9_-_125667494 | 1.25 |
ENST00000335387.5 ENST00000357244.2 ENST00000373665.2 |
RC3H2 |
ring finger and CCCH-type domains 2 |
chr20_-_4795747 | 1.25 |
ENST00000379376.2 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
chr14_+_103243813 | 1.25 |
ENST00000560371.1 ENST00000347662.4 ENST00000392745.2 ENST00000539721.1 ENST00000560463.1 |
TRAF3 |
TNF receptor-associated factor 3 |
chr5_-_150466692 | 1.22 |
ENST00000315050.7 ENST00000523338.1 ENST00000522100.1 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr10_+_104155450 | 1.21 |
ENST00000471698.1 ENST00000189444.6 |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr11_+_18287801 | 1.20 |
ENST00000532858.1 ENST00000405158.2 |
SAA1 |
serum amyloid A1 |
chr2_+_97202480 | 1.20 |
ENST00000357485.3 |
ARID5A |
AT rich interactive domain 5A (MRF1-like) |
chr14_+_24616588 | 1.16 |
ENST00000324103.6 ENST00000559260.1 |
RNF31 |
ring finger protein 31 |
chr19_+_35940486 | 1.16 |
ENST00000246549.2 |
FFAR2 |
free fatty acid receptor 2 |
chr9_+_127054254 | 1.15 |
ENST00000422297.1 |
NEK6 |
NIMA-related kinase 6 |
chr7_+_69064566 | 1.14 |
ENST00000403018.2 |
AUTS2 |
autism susceptibility candidate 2 |
chr5_+_118604385 | 1.12 |
ENST00000274456.6 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
chr11_+_18287721 | 1.11 |
ENST00000356524.4 |
SAA1 |
serum amyloid A1 |
chr6_+_144471643 | 1.07 |
ENST00000367568.4 |
STX11 |
syntaxin 11 |
chr5_-_141257954 | 1.07 |
ENST00000456271.1 ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1 |
protocadherin 1 |
chr10_+_13142075 | 1.07 |
ENST00000378757.2 ENST00000430081.1 ENST00000378752.3 ENST00000378748.3 |
OPTN |
optineurin |
chr14_-_103589246 | 1.06 |
ENST00000558224.1 ENST00000560742.1 |
LINC00677 |
long intergenic non-protein coding RNA 677 |
chr3_-_156878540 | 1.03 |
ENST00000461804.1 |
CCNL1 |
cyclin L1 |
chr12_-_132905789 | 1.00 |
ENST00000328957.8 |
GALNT9 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) |
chr5_-_158526756 | 1.00 |
ENST00000313708.6 ENST00000517373.1 |
EBF1 |
early B-cell factor 1 |
chr19_+_41725088 | 1.00 |
ENST00000301178.4 |
AXL |
AXL receptor tyrosine kinase |
chr1_-_89738528 | 1.00 |
ENST00000343435.5 |
GBP5 |
guanylate binding protein 5 |
chr5_+_159895275 | 0.99 |
ENST00000517927.1 |
MIR146A |
microRNA 146a |
chr10_+_13141585 | 0.98 |
ENST00000378764.2 |
OPTN |
optineurin |
chr17_-_4852332 | 0.98 |
ENST00000572383.1 |
PFN1 |
profilin 1 |
chr19_-_4182530 | 0.97 |
ENST00000601571.1 ENST00000601488.1 ENST00000305232.6 ENST00000381935.3 ENST00000337491.2 |
SIRT6 |
sirtuin 6 |
chr1_-_36615065 | 0.97 |
ENST00000373166.3 ENST00000373159.1 ENST00000373162.1 |
TRAPPC3 |
trafficking protein particle complex 3 |
chr2_+_228678550 | 0.96 |
ENST00000409189.3 ENST00000358813.4 |
CCL20 |
chemokine (C-C motif) ligand 20 |
chr3_+_111578131 | 0.96 |
ENST00000498699.1 |
PHLDB2 |
pleckstrin homology-like domain, family B, member 2 |
chr17_-_61777090 | 0.95 |
ENST00000578061.1 |
LIMD2 |
LIM domain containing 2 |
chr12_+_11802753 | 0.95 |
ENST00000396373.4 |
ETV6 |
ets variant 6 |
chr16_+_67282853 | 0.93 |
ENST00000299798.11 |
SLC9A5 |
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
chr4_+_74702214 | 0.93 |
ENST00000226317.5 ENST00000515050.1 |
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
chr2_+_201987200 | 0.92 |
ENST00000425030.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr19_-_46272462 | 0.91 |
ENST00000317578.6 |
SIX5 |
SIX homeobox 5 |
chr13_+_53602894 | 0.91 |
ENST00000219022.2 |
OLFM4 |
olfactomedin 4 |
chr6_-_30712313 | 0.90 |
ENST00000376377.2 ENST00000259874.5 |
IER3 |
immediate early response 3 |
chr10_+_13142225 | 0.90 |
ENST00000378747.3 |
OPTN |
optineurin |
chr20_-_45530365 | 0.90 |
ENST00000414085.1 |
RP11-323C15.2 |
RP11-323C15.2 |
chr10_+_22605374 | 0.89 |
ENST00000448361.1 |
COMMD3 |
COMM domain containing 3 |
chr2_+_97203082 | 0.89 |
ENST00000454558.2 |
ARID5A |
AT rich interactive domain 5A (MRF1-like) |
chr10_+_75668916 | 0.89 |
ENST00000481390.1 |
PLAU |
plasminogen activator, urokinase |
chr15_+_44719996 | 0.88 |
ENST00000559793.1 ENST00000558968.1 |
CTDSPL2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
chr1_-_209825674 | 0.87 |
ENST00000367030.3 ENST00000356082.4 |
LAMB3 |
laminin, beta 3 |
chr15_+_44719790 | 0.86 |
ENST00000558791.1 |
CTDSPL2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
chr10_+_30723045 | 0.85 |
ENST00000542547.1 ENST00000415139.1 |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
chr10_+_12391685 | 0.85 |
ENST00000378845.1 |
CAMK1D |
calcium/calmodulin-dependent protein kinase ID |
chr9_-_130693048 | 0.84 |
ENST00000388747.4 |
PIP5KL1 |
phosphatidylinositol-4-phosphate 5-kinase-like 1 |
chr7_+_143078652 | 0.83 |
ENST00000354434.4 ENST00000449423.2 |
ZYX |
zyxin |
chr5_+_10564432 | 0.83 |
ENST00000296657.5 |
ANKRD33B |
ankyrin repeat domain 33B |
chr1_-_153935983 | 0.83 |
ENST00000537590.1 ENST00000356205.4 |
SLC39A1 |
solute carrier family 39 (zinc transporter), member 1 |
chr10_+_22605304 | 0.82 |
ENST00000475460.2 ENST00000602390.1 ENST00000489125.2 ENST00000456711.1 ENST00000444869.1 |
COMMD3-BMI1 COMMD3 |
COMMD3-BMI1 readthrough COMM domain containing 3 |
chr15_+_57884086 | 0.81 |
ENST00000380569.2 ENST00000380561.2 ENST00000574161.1 ENST00000572390.1 ENST00000396180.1 ENST00000380560.2 |
GCOM1 |
GRINL1A complex locus 1 |
chr5_-_149792295 | 0.81 |
ENST00000518797.1 ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr1_-_1822495 | 0.80 |
ENST00000378609.4 |
GNB1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
chr16_-_66959429 | 0.80 |
ENST00000420652.1 ENST00000299759.6 |
RRAD |
Ras-related associated with diabetes |
chr1_-_153935938 | 0.80 |
ENST00000368621.1 ENST00000368623.3 |
SLC39A1 |
solute carrier family 39 (zinc transporter), member 1 |
chrX_+_152907913 | 0.79 |
ENST00000370167.4 |
DUSP9 |
dual specificity phosphatase 9 |
chr6_+_106534192 | 0.78 |
ENST00000369091.2 ENST00000369096.4 |
PRDM1 |
PR domain containing 1, with ZNF domain |
chr19_-_46272106 | 0.78 |
ENST00000560168.1 |
SIX5 |
SIX homeobox 5 |
chr12_+_78224667 | 0.77 |
ENST00000549464.1 |
NAV3 |
neuron navigator 3 |
chr19_+_41725140 | 0.77 |
ENST00000359092.3 |
AXL |
AXL receptor tyrosine kinase |
chr10_-_7708918 | 0.76 |
ENST00000256861.6 ENST00000397146.2 ENST00000446830.2 ENST00000397145.2 |
ITIH5 |
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
chr12_+_48499252 | 0.75 |
ENST00000549003.1 ENST00000550924.1 |
PFKM |
phosphofructokinase, muscle |
chr17_+_40440094 | 0.75 |
ENST00000546010.2 |
STAT5A |
signal transducer and activator of transcription 5A |
chr5_+_14143728 | 0.74 |
ENST00000344204.4 ENST00000537187.1 |
TRIO |
trio Rho guanine nucleotide exchange factor |
chr7_+_143771275 | 0.74 |
ENST00000408898.2 |
OR2A25 |
olfactory receptor, family 2, subfamily A, member 25 |
chr15_+_57884117 | 0.73 |
ENST00000267853.5 |
MYZAP |
myocardial zonula adherens protein |
chr12_-_76425368 | 0.73 |
ENST00000602540.1 |
PHLDA1 |
pleckstrin homology-like domain, family A, member 1 |
chr12_+_7053228 | 0.72 |
ENST00000540506.2 |
C12orf57 |
chromosome 12 open reading frame 57 |
chr4_+_185395947 | 0.72 |
ENST00000605834.1 |
RP11-326I11.3 |
RP11-326I11.3 |
chr3_-_111852061 | 0.71 |
ENST00000488580.1 ENST00000460387.2 ENST00000484193.1 ENST00000487901.1 |
GCSAM |
germinal center-associated, signaling and motility |
chr4_+_103422471 | 0.70 |
ENST00000226574.4 ENST00000394820.4 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr11_+_10476851 | 0.70 |
ENST00000396553.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr19_-_4831701 | 0.69 |
ENST00000248244.5 |
TICAM1 |
toll-like receptor adaptor molecule 1 |
chr14_-_69446034 | 0.69 |
ENST00000193403.6 |
ACTN1 |
actinin, alpha 1 |
chr21_+_34775698 | 0.68 |
ENST00000381995.1 |
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr1_+_151171012 | 0.68 |
ENST00000349792.5 ENST00000409426.1 ENST00000441902.2 ENST00000368890.4 ENST00000424999.1 ENST00000368888.4 |
PIP5K1A |
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha |
chr5_-_58652788 | 0.67 |
ENST00000405755.2 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
chr14_+_75988768 | 0.67 |
ENST00000286639.6 |
BATF |
basic leucine zipper transcription factor, ATF-like |
chr7_+_120629653 | 0.66 |
ENST00000450913.2 ENST00000340646.5 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
chr5_-_178054014 | 0.65 |
ENST00000520957.1 |
CLK4 |
CDC-like kinase 4 |
chr1_-_94079648 | 0.65 |
ENST00000370247.3 |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
chr2_+_202047596 | 0.65 |
ENST00000286186.6 ENST00000360132.3 |
CASP10 |
caspase 10, apoptosis-related cysteine peptidase |
chr4_-_185395672 | 0.64 |
ENST00000393593.3 |
IRF2 |
interferon regulatory factor 2 |
chr4_+_41614720 | 0.64 |
ENST00000509277.1 |
LIMCH1 |
LIM and calponin homology domains 1 |
chr12_+_7053172 | 0.63 |
ENST00000229281.5 |
C12orf57 |
chromosome 12 open reading frame 57 |
chr21_+_34775181 | 0.63 |
ENST00000290219.6 |
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr9_-_125667618 | 0.63 |
ENST00000423239.2 |
RC3H2 |
ring finger and CCCH-type domains 2 |
chr7_-_24797032 | 0.63 |
ENST00000409970.1 ENST00000409775.3 |
DFNA5 |
deafness, autosomal dominant 5 |
chr6_-_24720226 | 0.62 |
ENST00000378102.3 |
C6orf62 |
chromosome 6 open reading frame 62 |
chr8_+_21899898 | 0.61 |
ENST00000518533.1 ENST00000359441.3 |
FGF17 |
fibroblast growth factor 17 |
chr4_-_140222358 | 0.61 |
ENST00000505036.1 ENST00000544855.1 ENST00000539002.1 |
NDUFC1 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
chr19_+_6740888 | 0.61 |
ENST00000596673.1 |
TRIP10 |
thyroid hormone receptor interactor 10 |
chr2_+_234602305 | 0.60 |
ENST00000406651.1 |
UGT1A6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
chr19_-_54984354 | 0.59 |
ENST00000301200.2 |
CDC42EP5 |
CDC42 effector protein (Rho GTPase binding) 5 |
chr5_-_54468974 | 0.58 |
ENST00000381375.2 ENST00000296733.1 ENST00000322374.6 ENST00000334206.5 ENST00000331730.3 |
CDC20B |
cell division cycle 20B |
chr9_+_127054217 | 0.58 |
ENST00000394199.2 ENST00000546191.1 |
NEK6 |
NIMA-related kinase 6 |
chr22_-_37640277 | 0.58 |
ENST00000401529.3 ENST00000249071.6 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr2_-_177502659 | 0.57 |
ENST00000295549.4 |
AC017048.3 |
long intergenic non-protein coding RNA 1116 |
chr11_-_6633799 | 0.57 |
ENST00000299424.4 |
TAF10 |
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
chr22_-_37640456 | 0.56 |
ENST00000405484.1 ENST00000441619.1 ENST00000406508.1 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr6_+_29910301 | 0.56 |
ENST00000376809.5 ENST00000376802.2 |
HLA-A |
major histocompatibility complex, class I, A |
chr6_+_32121908 | 0.56 |
ENST00000375143.2 ENST00000424499.1 |
PPT2 |
palmitoyl-protein thioesterase 2 |
chr1_-_8000872 | 0.56 |
ENST00000377507.3 |
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
chr15_+_44719970 | 0.56 |
ENST00000558966.1 |
CTDSPL2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
chr12_+_49761224 | 0.56 |
ENST00000553127.1 ENST00000321898.6 |
SPATS2 |
spermatogenesis associated, serine-rich 2 |
chr9_-_127952032 | 0.56 |
ENST00000456642.1 ENST00000373546.3 ENST00000373547.4 |
PPP6C |
protein phosphatase 6, catalytic subunit |
chr20_+_18488528 | 0.55 |
ENST00000377465.1 |
SEC23B |
Sec23 homolog B (S. cerevisiae) |
chr21_+_34775772 | 0.54 |
ENST00000405436.1 |
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr15_+_27216530 | 0.54 |
ENST00000555083.1 |
GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
chr19_+_45251804 | 0.54 |
ENST00000164227.5 |
BCL3 |
B-cell CLL/lymphoma 3 |
chr11_-_128392085 | 0.52 |
ENST00000526145.2 ENST00000531611.1 ENST00000319397.6 ENST00000345075.4 ENST00000535549.1 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr14_+_24521202 | 0.52 |
ENST00000334420.7 ENST00000342740.5 |
LRRC16B |
leucine rich repeat containing 16B |
chr11_-_44331679 | 0.52 |
ENST00000329255.3 |
ALX4 |
ALX homeobox 4 |
chr13_+_108921977 | 0.52 |
ENST00000430559.1 ENST00000375887.4 |
TNFSF13B |
tumor necrosis factor (ligand) superfamily, member 13b |
chr1_+_6845497 | 0.52 |
ENST00000473578.1 ENST00000557126.1 |
CAMTA1 |
calmodulin binding transcription activator 1 |
chr12_-_48499591 | 0.52 |
ENST00000551330.1 ENST00000004980.5 ENST00000339976.6 ENST00000448372.1 |
SENP1 |
SUMO1/sentrin specific peptidase 1 |
chr19_-_4182497 | 0.51 |
ENST00000597896.1 |
SIRT6 |
sirtuin 6 |
chr22_-_20792089 | 0.51 |
ENST00000405555.3 ENST00000266214.5 |
SCARF2 |
scavenger receptor class F, member 2 |
chr20_+_18488137 | 0.51 |
ENST00000450074.1 ENST00000262544.2 ENST00000336714.3 ENST00000377475.3 |
SEC23B |
Sec23 homolog B (S. cerevisiae) |
chr9_+_82187487 | 0.51 |
ENST00000435650.1 ENST00000414465.1 ENST00000376537.4 ENST00000376534.4 |
TLE4 |
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr9_+_82187630 | 0.50 |
ENST00000265284.6 |
TLE4 |
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr19_+_42381173 | 0.50 |
ENST00000221972.3 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr12_-_62997214 | 0.49 |
ENST00000408887.2 |
C12orf61 |
chromosome 12 open reading frame 61 |
chr22_-_39151434 | 0.47 |
ENST00000439339.1 |
SUN2 |
Sad1 and UNC84 domain containing 2 |
chr3_+_197518100 | 0.47 |
ENST00000438796.2 ENST00000414675.2 ENST00000441090.2 ENST00000334859.4 ENST00000425562.2 |
LRCH3 |
leucine-rich repeats and calponin homology (CH) domain containing 3 |
chr1_-_32403903 | 0.47 |
ENST00000344035.6 ENST00000356536.3 |
PTP4A2 |
protein tyrosine phosphatase type IVA, member 2 |
chr19_+_40697514 | 0.46 |
ENST00000253055.3 |
MAP3K10 |
mitogen-activated protein kinase kinase kinase 10 |
chr18_+_3252265 | 0.46 |
ENST00000580887.1 ENST00000536605.1 |
MYL12A |
myosin, light chain 12A, regulatory, non-sarcomeric |
chr15_-_66084621 | 0.45 |
ENST00000564674.1 |
DENND4A |
DENN/MADD domain containing 4A |
chr14_-_69262916 | 0.45 |
ENST00000553375.1 |
ZFP36L1 |
ZFP36 ring finger protein-like 1 |
chr3_-_111852128 | 0.45 |
ENST00000308910.4 |
GCSAM |
germinal center-associated, signaling and motility |
chr11_+_66025274 | 0.44 |
ENST00000461611.1 |
KLC2 |
kinesin light chain 2 |
chr12_+_7052974 | 0.44 |
ENST00000544681.1 ENST00000537087.1 |
C12orf57 |
chromosome 12 open reading frame 57 |
chr6_-_150039170 | 0.44 |
ENST00000458696.2 ENST00000392273.3 |
LATS1 |
large tumor suppressor kinase 1 |
chr4_-_103749179 | 0.44 |
ENST00000502690.1 |
UBE2D3 |
ubiquitin-conjugating enzyme E2D 3 |
chr3_+_137717571 | 0.43 |
ENST00000343735.4 |
CLDN18 |
claudin 18 |
chr14_+_32798462 | 0.43 |
ENST00000280979.4 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
chr2_+_179059365 | 0.43 |
ENST00000190611.4 |
OSBPL6 |
oxysterol binding protein-like 6 |
chr19_-_46145696 | 0.43 |
ENST00000588172.1 |
EML2 |
echinoderm microtubule associated protein like 2 |
chr11_-_46141338 | 0.43 |
ENST00000529782.1 ENST00000532010.1 ENST00000525438.1 ENST00000533757.1 ENST00000527782.1 |
PHF21A |
PHD finger protein 21A |
chr6_+_135502466 | 0.43 |
ENST00000367814.4 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr11_-_3862206 | 0.43 |
ENST00000351018.4 |
RHOG |
ras homolog family member G |
chr4_+_146560245 | 0.43 |
ENST00000541599.1 |
MMAA |
methylmalonic aciduria (cobalamin deficiency) cblA type |
chr15_+_57884199 | 0.42 |
ENST00000587652.1 ENST00000380568.3 ENST00000380565.4 ENST00000380563.2 |
GCOM1 MYZAP POLR2M |
GRINL1A complex locus 1 myocardial zonula adherens protein polymerase (RNA) II (DNA directed) polypeptide M |
chr2_+_202047843 | 0.41 |
ENST00000272879.5 ENST00000374650.3 ENST00000346817.5 ENST00000313728.7 ENST00000448480.1 |
CASP10 |
caspase 10, apoptosis-related cysteine peptidase |
chr8_+_42128861 | 0.41 |
ENST00000518983.1 |
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
chr2_+_17721920 | 0.40 |
ENST00000295156.4 |
VSNL1 |
visinin-like 1 |
chr7_-_127032363 | 0.40 |
ENST00000393312.1 |
ZNF800 |
zinc finger protein 800 |
chr11_-_64570624 | 0.40 |
ENST00000439069.1 |
MAP4K2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
chr4_+_103422499 | 0.40 |
ENST00000511926.1 ENST00000507079.1 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr1_-_209824643 | 0.39 |
ENST00000391911.1 ENST00000415782.1 |
LAMB3 |
laminin, beta 3 |
chr1_+_182584314 | 0.39 |
ENST00000566297.1 |
RP11-317P15.4 |
RP11-317P15.4 |
chr3_+_57261859 | 0.39 |
ENST00000495803.1 ENST00000444459.1 |
APPL1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.4 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
1.5 | 7.5 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
1.4 | 5.4 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
1.1 | 4.4 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
1.1 | 3.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.1 | 4.3 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.8 | 2.3 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.7 | 3.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.7 | 6.8 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.6 | 3.8 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.5 | 2.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 1.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
0.5 | 1.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 1.8 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.4 | 4.3 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.4 | 1.7 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.4 | 2.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.2 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.4 | 9.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.4 | 1.1 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.4 | 2.1 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.3 | 1.0 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.3 | 1.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.3 | 1.8 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 0.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.3 | 0.8 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 0.8 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 1.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 1.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 1.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 1.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.8 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.2 | 2.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.7 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.3 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
0.1 | 0.4 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.1 | 0.4 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.1 | 3.2 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 1.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 1.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 1.0 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 0.4 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.7 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 3.8 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 0.3 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 0.9 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 0.3 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 1.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.9 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 1.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.5 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.2 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.1 | 0.2 | GO:1903384 | enzyme active site formation(GO:0018307) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) detoxification of mercury ion(GO:0050787) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.1 | 0.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.4 | GO:0060527 | embryonic hindgut morphogenesis(GO:0048619) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.8 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 1.8 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.4 | GO:2001205 | TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of osteoclast development(GO:2001205) |
0.0 | 0.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.0 | 2.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.9 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 1.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.3 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 1.7 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.2 | GO:0050976 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.0 | 0.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 2.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 2.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 1.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.6 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.0 | 1.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.1 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.0 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.2 | GO:0060161 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.0 | 1.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.0 | 1.7 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 2.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 2.7 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 0.1 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.2 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.2 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.8 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 1.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.9 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 1.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.7 | 6.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 6.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 1.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.8 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 2.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.8 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 1.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 2.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.2 | GO:0035101 | FACT complex(GO:0035101) |
0.0 | 1.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 2.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 2.1 | GO:1904724 | specific granule lumen(GO:0035580) tertiary granule lumen(GO:1904724) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 3.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 1.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 2.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 2.1 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 1.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 2.2 | GO:0031674 | I band(GO:0031674) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 6.2 | GO:0046979 | TAP2 binding(GO:0046979) |
0.8 | 3.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.7 | 3.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.6 | 10.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.5 | 7.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 1.5 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 1.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 1.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 2.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 1.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 1.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.1 | 0.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 10.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.5 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 1.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 4.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 3.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.4 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 2.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 2.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 5.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.0 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 1.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 5.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 4.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.0 | 1.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 1.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 2.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 1.8 | GO:0000149 | SNARE binding(GO:0000149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 7.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 1.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 24.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 5.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 2.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 2.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 6.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 10.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 1.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 10.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 6.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 15.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 11.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 4.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 2.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |